中国CT和MRI杂志2024,Vol.22Issue(10) :121-123.DOI:10.3969/j.issn.1672-5131.2024.10.039

基于CT的动脉增强分数预测胃癌新辅助化疗联合免疫治疗反应的价值

Value of CT-based Arterial Enhancement Fraction in Predicting the Response of Neoadjuvant Chemotherapy Combined with Immunotherapy in Gastric Cancer

徐敏 张文娟 邓娟 任铁柱 杨晶晶 席华泽 袁隆 周俊林
中国CT和MRI杂志2024,Vol.22Issue(10) :121-123.DOI:10.3969/j.issn.1672-5131.2024.10.039

基于CT的动脉增强分数预测胃癌新辅助化疗联合免疫治疗反应的价值

Value of CT-based Arterial Enhancement Fraction in Predicting the Response of Neoadjuvant Chemotherapy Combined with Immunotherapy in Gastric Cancer

徐敏 1张文娟 1邓娟 1任铁柱 1杨晶晶 1席华泽 1袁隆 1周俊林1
扫码查看

作者信息

  • 1. 兰州大学第二医院放射科;兰州大学第二临床医学院;甘肃省医学影像重点实验室;医学影像人工智能甘肃省国际科技合作基地(甘肃兰州 730030)
  • 折叠

摘要

目的 探讨CT动脉增强分数(arterial enhancement fraction,AEF)与胃癌新辅助化疗联合免疫治疗反应的相关性,为胃癌患者化疗联合免疫治疗的疗效预测提供影像学参考.方法 回顾性收集经活检病理证实为胃腺癌并接受新辅助化疗联合免疫治疗的52例患者,所有患者均经过治疗前常规增强CT扫描.根据治疗后手术病理结果,将患者分为治疗较好(Becker分级:Grade 1-2:肿瘤残留≤50%)与疗效不佳(Grade 3:肿瘤残留>50%).记录部分形态学特征,测量肿瘤大小及平扫期和增强动脉期、静脉期CT值,计算动脉增强分数.比较各CT参数的组间差异,采用单因素及多因素logistic回归筛选疗效相关独立预测因子,绘制受试者工作特征(ROC)曲线,计算曲线下面积(AUC),评估模型的预测效能.结果 疗效较好的患者更多表现为浆膜面光滑(44.7%vs7.1%;P=0.019),病灶AEF高于疗效不佳组[82.21(69.68,107.64)vs 59.31±5.70,P=0.003)].多因素logistic回归(向前)结果显示,具有浆膜面光滑特征(OR=11.317,95%CI:1.169-109.545,P=0.036)和较高的AEF(OR=1.045,95%CI:1.012-1.080,P=0.007)是疗效较好的独立预测因素.ROC曲线显示,多变量logistic回归模型的AUC=0.853,95%CI:0.737-0.970,敏感度:84.2%,特异度:85.7%.结论 AEF结合浆膜特征可预测胃癌对新辅助化疗联合免疫治疗的反应,有助于患者术前治疗方案的选择.

Abstract

Objective To explore the correlation between CT-based arterial enhancement fraction(AEF)and tumor shrinkage after neoadjuvant chemotherapy combined with immunotherapy for gastric cancer,so as to provide an imaging reference for predicting the therapeutic effect of combination chemotherapy and immunotherapy for gastric cancer patients.Methods 52 patients with gastric adenocarcinoma confirmed by biopsy and pathology and receiving neoadjuvant chemotherapy combined with immunotherapy were retrospectively collected.All patients underwent enhanced CT scanning before treatment.According to the postoperative pathological results,the patients were divided into good treatment(Becker scale:Grade 1-2:tumor residue<50%)and poor efficacy(Grade 3:tumor residue>50%).Some morphological features were recorded,tumor size and CT values of normal scan and enhanced phase were measured,and the artery enhancement fraction was calculated.The inter-group differences of CT parameters were compared,univariate and multivariate logistic regression were used to screen independent predictors of efficacy,receiver operating characteristic(ROC)curve was plotted,and area under the curve(AUC)was calculated to evaluate the predictive efficacy of the model.Results Smooth serous membrane was more common in patients with better efficacy(44.7%vs7.1%;the AEF of the lesion was higher than that of the poor treatment group(82.21(69.68,107.64)vs 59.31±5.70,P=0.003).Multivariate logistic regression(forward)results showed that there were smooth serous membrane features(OR=11.317,95%CI:1.169-109.545,P=0.036)and higher AEF(OR=1.045,95%CI:1.012-1.080,P=0.007)were independent predictors of better efficacy.ROC curve showed that AUC of multivariate logistic regression model was 0.853,95%CI:0.737-0.970,sensitivity:84.2%,specificity:85.7%.Conclusion AEF combined with serous membrane characteristics can predict the degree of tumor regression after neoadjuvant chemotherapy combined with immunotherapy for gastric cancer,which is helpful for the selection of preoperative treatment for patients.

关键词

CT/动脉增强分数/胃癌/免疫治疗/新辅助化疗

Key words

CT/Artery Enhancement Fraction/Gastric Cancer/Immunotherapy/Neoadjuvant Chemotherapy

引用本文复制引用

基金项目

国家自然科学基金(82102151)

兰州市青年科技人才创新项目(2023-2-44)

出版年

2024
中国CT和MRI杂志
北京大学深圳临床医学院 北京大学第一医院

中国CT和MRI杂志

CSTPCD
影响因子:1.578
ISSN:1672-5131
段落导航相关论文